NICE-NEC, a phase II study of platinum-doublet chemotherapy in combination with nivolumab as first-line treatment in subjects with unresectable, locally advanced or metastatic grade 3 neuroendocrine neoplasms (NENs) of the gastroenteropancreatic tract or of unknown origin. GETNE-T1913
No Thumbnail Available
Identifiers
Date
2020-09-01
Authors
Riesco Martinez, M. C.
Capdevila, J.
Alonso, V.
Teule, A.
Grande, E.
Jimenez-Fonseca, P.
Benavent, M.
Alonso Gordoa, T.
Custodio, A.
Hierro Carbo, C.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
